QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
NASDAQ:CABA

Cabaletta Bio (CABA) News Today

$15.37
-0.45 (-2.84%)
(As of 09/25/2023 ET)
Compare
Today's Range
$15.25
▼
$16.07
50-Day Range
$11.84
▼
$18.65
52-Week Range
$0.61
▼
$19.34
Volume
609,988 shs
Average Volume
541,444 shs
Market Capitalization
$611.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
finance.yahoo.com logoWhat Makes Cabaletta Bio, Inc. (CABA) a Good Fit for 'Trend Investing'
finance.yahoo.com - September 25 at 3:04 PM
markets.businessinsider.com logoPromising Safety and Efficacy Data for Cabaletta Bio’s CD19 CAR-T Therapy Bolsters Buy Recommendation
markets.businessinsider.com - September 23 at 2:56 PM
msn.com logoCabaletta Bio: How Long Can Unique Cell Therapy Developer's Sensational Bull Run Continue?
msn.com - September 19 at 9:53 AM
MarketBeat logoWells Fargo & Company Raises Cabaletta Bio (NASDAQ:CABA) Price Target to $39.00
americanbankingnews.com - September 19 at 3:58 AM
MarketBeat logoCabaletta Bio (NASDAQ:CABA) Shares Gap Up Following Analyst Upgrade
americanbankingnews.com - September 19 at 1:30 AM
marketbeat.com logoCabaletta Bio, Inc. (NASDAQ:CABA) Sees Significant Decline in Short Interest
marketbeat.com - September 15 at 11:36 PM
msn.com logoCabaletta Bio, Inc. (CABA) is on the Move, Here's Why the Trend Could be Sustainable
msn.com - September 8 at 6:45 PM
marketbeat.com logoCabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of "Buy" by Brokerages
marketbeat.com - September 6 at 2:20 AM
markets.businessinsider.com logoAnalyst Ratings for Cabaletta Bio
markets.businessinsider.com - September 5 at 5:28 PM
cnbc.com logoThis little-known biotech stock has 'blockbuster potential,' says Citi
cnbc.com - September 5 at 5:28 PM
markets.businessinsider.com logoCabaletta Bio (CABA) Receives a Buy from Citi
markets.businessinsider.com - September 5 at 7:31 AM
finance.yahoo.com logoWall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade
finance.yahoo.com - August 31 at 5:53 PM
finance.yahoo.com logoCabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
finance.yahoo.com - August 30 at 2:14 PM
marketbeat.com logoBarclays PLC Purchases 63,052 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA)
marketbeat.com - August 27 at 4:03 AM
finance.yahoo.com logoLab Notes: Wistar, Coriell researchers identify potential target for gastric cancers treatment
finance.yahoo.com - August 25 at 3:39 PM
finance.yahoo.com logoRecent Price Trend in Cabaletta Bio, Inc. (CABA) is Your Friend, Here's Why
finance.yahoo.com - August 23 at 4:06 PM
lse.co.uk logoOxford BioMedica expands licence deal with Cabaletta Bio
lse.co.uk - August 22 at 7:07 AM
finance.yahoo.com logoWe Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth
finance.yahoo.com - August 21 at 9:45 AM
finance.yahoo.com logoDoes Cabaletta Bio, Inc. (CABA) Have the Potential to Rally 27.85% as Wall Street Analysts Expect?
finance.yahoo.com - August 15 at 4:34 PM
msn.com logoGuggenheim Reiterates Cabaletta Bio (CABA) Buy Recommendation
msn.com - August 14 at 4:25 PM
marketbeat.com logoCabaletta Bio, Inc. (NASDAQ:CABA) Forecasted to Earn Q1 2024 Earnings of ($0.37) Per Share
marketbeat.com - August 14 at 4:44 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Cabaletta Bio (CABA)
markets.businessinsider.com - August 12 at 12:38 AM
msn.com logoHC Wainwright & Co. Maintains Cabaletta Bio (CABA) Buy Recommendation
msn.com - August 12 at 12:38 AM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know
markets.businessinsider.com - August 12 at 12:38 AM
marketbeat.com logoCabaletta Bio (NASDAQ:CABA) Price Target Increased to $17.00 by Analysts at HC Wainwright
marketbeat.com - August 11 at 8:00 AM
finance.yahoo.com logoCabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - August 10 at 10:20 AM
msn.com logoCabaletta Bio (CABA) Price Target Increased by 20.00% to 17.34
msn.com - August 2 at 10:40 AM
msn.com logoTop Growth Stocks for August 2023
msn.com - August 1 at 7:40 PM
finance.yahoo.com logoCabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
finance.yahoo.com - July 24 at 8:14 AM
msn.com logoGuggenheim starts Cabaletta at buy, citing CAR-T therapy CABA-201
msn.com - July 19 at 7:25 PM
nasdaq.com logoGuggenheim Initiates Coverage of Cabaletta Bio (CABA) with Buy Recommendation
nasdaq.com - July 19 at 12:21 AM
benzinga.com logoAnalyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach
benzinga.com - July 18 at 7:21 PM
finance.yahoo.com logoWhy Shares of Cabaletta Bio Are Up Tuesday
finance.yahoo.com - July 18 at 7:21 PM
marketbeat.com logoShort Interest in Cabaletta Bio, Inc. (NASDAQ:CABA) Rises By 22.3%
marketbeat.com - July 18 at 6:42 AM
marketbeat.com logoJennison Associates LLC Invests $6.46 Million in Cabaletta Bio, Inc. (NASDAQ:CABA)
marketbeat.com - July 16 at 5:15 AM
msn.com logoCabaletta Bio: Pioneering New Therapies In Autoimmune Disease
msn.com - July 12 at 8:01 AM
finance.yahoo.com logoCABA - Cabaletta Bio, Inc.
finance.yahoo.com - July 8 at 1:45 PM
finance.yahoo.com logoInstitutional investors in Cabaletta Bio, Inc. (NASDAQ:CABA) lost 18% last week but have reaped the benefits of longer-term growth
finance.yahoo.com - May 24 at 9:44 AM
finance.yahoo.com logoCabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - May 22 at 7:22 PM
bizjournals.com logoPrelude Therapeutics, Cabaletta Bio expect to raise up to $161M combined in public stock sales
bizjournals.com - May 22 at 2:22 PM
marketbeat.com logoCabaletta Bio, Inc. (NASDAQ:CABA) Insider Sells $259,820.00 in Stock
marketbeat.com - May 19 at 9:49 PM
msn.com logoThese stocks are seeing some short squeeze action - watch out above
msn.com - May 18 at 12:16 PM
msn.com logoCabaletta Bio up 1%, prices $87M offering
msn.com - May 18 at 7:16 AM
finance.yahoo.com logoCabaletta Bio Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - May 18 at 2:15 AM
seekingalpha.com logoCabaletta Bio jumps 16% as FDA clears trial for myositis candidate
seekingalpha.com - May 17 at 4:14 PM
finance.yahoo.com logoCabaletta Bio Announces Proposed Public Offering of Common Stock
finance.yahoo.com - May 17 at 4:14 PM
marketwatch.com logoThinking about buying stock in Cabaletta Bio, SNDL, Roblox, DraftKings, or Riot Platforms?
marketwatch.com - May 17 at 4:16 AM
marketwatch.com logoCabaletta Bio Shares Rose 15% After FDA Approves IND Application for CABA-201
marketwatch.com - May 16 at 6:14 PM
msn.com logoCabaletta Bio Jumps after New Trial Plans
msn.com - May 16 at 6:14 PM
finance.yahoo.com logoCabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
finance.yahoo.com - May 16 at 8:14 AM
Get Cabaletta Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter.



CABA Media Mentions By Week

CABA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CABA
News Sentiment
▼
0.09

0.51
▲
Average
Medical
News Sentiment

CABA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CABA Articles
This Week
▼
6

2
▲
CABA Articles
Average Week

Get Cabaletta Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CABA) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -